Showing results (1771-1780 of 2,044) with videos related to

Sort By:
Pageof 205
Current Alzheimer Research|August 30, 2017
miRNAs in Alzheimer Disease - A Therapeutic PerspectivePriya Gupta, Surajit Bhattacharjee, Ashish Ranjan Sharma, et al.
Current Alzheimer Research|September 29, 2015
Neurobiology of Alzheimer's Disease: Integrated Molecular, Physiological, Anatomical, Biomarker, and Cognitive DimensionsJoel Raskin, Jeffrey Cummings, John Hardy, et al.
Current Alzheimer Research|July 22, 2017
iTRAQ-based Proteomic Analysis of APPSw,Ind Mice Provides Insights into the Early Changes in Alzheimer's DiseaseNan Li, Pinghong Hu, Tiantian Xu, et al.
Current Alzheimer Research|June 25, 2016
The Long Non-Coding RNAs in Neurodegenerative Diseases: Novel Mechanisms of PathogenesisPaola Riva, Antonia Ratti, Marco Venturin
Current Alzheimer Research|July 1, 2016
Targeting Ras Activity Prevented Amyloid Beta-Induced Aberrant Neuronal Cell Cycle Re-Entry and DeathM Murat Koseoglu, Bagdeser Akdogan Ozdilek, Umidahan Djakbarova, et al.
Current Alzheimer Research|July 18, 2017
CDK5 and MAPT Gene Expression in Alzheimer's Disease Brain SamplesJosianne T Fukasawa, Roger W de Labio, Lucas T Rasmussen, et al.
Current Alzheimer Research|September 23, 2015
Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's DiseaseBarbara J Strupp, Brian E Powers, Ramon Velazquez, et al.
Current Alzheimer Research|November 17, 2015
Integration of (18)FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's DiseaseAntonio Giuliano Zippo, Isabella Castiglioni
Current Alzheimer Research|November 17, 2015
Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of ADFrancesca Gallivanone, Pasquale Anthony Della Rosa, Isabella Castiglioni
Current Alzheimer Research|November 17, 2015
Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?José Joaquín Merino, Vilma Muñetón-Gómez, María-Isabel Alvárez, et al.
Pageof 205